custom HuCAL recombinant Fab antibody

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98026Q00977

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Classification Code

6506

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a solicitation for the procurement of a custom HuCAL recombinant Fab antibody. This opportunity, identified by solicitation number 75N98026Q00977, is a combined synopsis/solicitation for commercial items, prepared in accordance with FAR Subpart 12.6 and supplemented by additional information provided in the notice. The procurement is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is intended to result in a firm-fixed-price contract or purchase order awarded to the offeror whose proposal represents the best value to the Government. The scope of this procurement centers on the acquisition of a custom HuCAL recombinant Fab antibody, a specialized biological product. The intended outcome is to secure a high-quality, commercially available antibody that meets the specific requirements of NIH research and operational needs. Offerors are expected to provide proposals that detail their ability to deliver the specified antibody, ensuring compliance with all relevant commercial standards and government requirements. Key requirements include adherence to the NAICS code 325414, which covers Biological Product (except Diagnostic) Manufacturing. The small business size standard for this code is 1,250 employees, and the procurement is unrestricted, allowing both large and small businesses to compete. The product service code associated with this requirement is 6506, further indicating the focus on medical and biological products. The contracting entity for this solicitation is the NIH Office of Logistics and Acquisition Operations (OLAO), a federal office within the Department of Health and Human Services. The primary point of contact for this opportunity is Jaddua C. Johnston, who can be reached via email at [email protected]. The solicitation was posted on August 18, 2026, with responses due by August 24, 2026. This procurement is classified as a competitive, full and open competition, with no set-aside requirements or special restrictions. The solicitation and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular as of August 7, 2026. Contractors interested in this opportunity should review the solicitation details and attachments available on SAM.gov (Opportunity ID: bc1edce8e26d48a5b83bc627e54950e4) to ensure alignment with their capabilities and compliance with all stated requirements. In summary, this notice represents a straightforward, competitive procurement for a custom HuCAL recombinant Fab antibody, with the NIH seeking proposals from qualified commercial manufacturers. The contract will be awarded based on best value, and all interested parties are encouraged to review the solicitation and submit their proposals by the specified deadline.